EUVIMED · CrossrefZeitschrift
Dermatology and Therapy
ISSN 2190-9172 · Springer Science and Business Media LLC
Neueste Artikel
Defining “Moderate” Psoriasis: A Targeted Review of the Medical Literature and Published Treatment Guidelines
Adjunctive Efficacy of a Ceramide-Containing Repair and Moisturizing Cream in the Management of Mild-to-Moderate Plaque Psoriasis
Forty-Eight-Week Real-World Outcomes of Ritlecitinib in Alopecia Areata: Delayed Responses and Predictive Value of Change in SALT Score at Week 24
Comparative Efficacy of Novel Non-steroidal Topical Therapies for Atopic Dermatitis: A Systematic Review and Network Meta-analysis
Dermatologist or AI? Patient Preferences in Skin Assessment
Long-Term Outcomes of Image-Guided Superficial Radiation Therapy for Stage I–II Nonmelanoma Skin Cancer: A Real-World Retrospective Cohort Study
Switching to Tildrakizumab 200 mg after Anti-IL-17 Failure in Moderate-to-Severe Psoriasis: A 52-Week Prospective Real-World Study
Self-Reported Disease Severity and Treatment Experience among Individuals Reporting Healthcare Professional-Diagnosed Chronic Hand Eczema: Findings from the Cross-Sectional CHECK-US Study
Real-World Effectiveness of Risankizumab for Moderate-to-Severe Plaque Psoriasis by Sub-populations: Interim Analysis from VALUE at 37 Months
Treat-to-Target in Atopic Dermatitis: An Italian Survey and Expert Opinion on Clinical Practice and Unmet Needs
Perimenopause and Menopause: Estrogen-Deficient Skin and Impaired Quality of Life—Dermal Aging a Visible Mirror Reflecting Internal Aging and Health
How Patients with Atopic Dermatitis Experience Topical Therapy: A Real-World Analysis of Impact, Treatment Satisfaction, and HCP Communication
Real-World Patient and Disease Characteristics, Treatment Outcomes and Satisfaction in Psoriasis: A Cross-Sectional and Retrospective Comparison of Advanced Therapies and Severities
Exploring How Healthcare Professionals Diagnose and Manage Vitiligo: Global VALIANT Study Findings and Recommendations
Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis
Pediatric Psoriasis: Comorbidities, Treatment Challenges and Unmet Needs
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study
Efficacy and Safety of a Topical Skincare Regimen with Tripeptide/Hexapeptide following Aesthetic Procedures: Analysis of Two Randomized, Split-Face Trials in Asian Subjects
Effectiveness, Safety, and Drug Survival of Bimekizumab in Chronic Plaque Psoriasis over 2 Years: Real-World Experience from Northern Italy
Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial
The State of the Art in Chronic Prurigo Nodularis
Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
Collagen, Curcumin, and Glutathione to Enhance Dermal Health in Aging Women with Declining Estrogen Levels —A Narrative Review
Addictions in Hidradenitis Suppurativa: A Cross-Sectional Pilot Study
The Prevalence and Burden of Truncal Acne
Understanding Social Drivers of Health, Burden, and Impact of Hidradenitis Suppurativa among Different Racial and Ethnic Groups in the USA
Efficacy of Remibrutinib versus Dupilumab at Early Timepoints in Chronic Spontaneous Urticaria: US Phase 3b Study Design (RECLAIM)
Environmental and Neighborhood Determinants of Psoriasis: A Systematic Review of Pollution, Built Environment, and Socioeconomic Vulnerability on Psoriasis
EUVIMED